289 related articles for article (PubMed ID: 22266848)
1. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
2. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
3. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.
Besmer DM; Curry JM; Roy LD; Tinder TL; Sahraei M; Schettini J; Hwang SI; Lee YY; Gendler SJ; Mukherjee P
Cancer Res; 2011 Jul; 71(13):4432-42. PubMed ID: 21558393
[TBL] [Abstract][Full Text] [Related]
5. The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.
Tréhoux S; Duchêne B; Jonckheere N; Van Seuningen I
Biochem Biophys Res Commun; 2015 Jan; 456(3):757-62. PubMed ID: 25511698
[TBL] [Abstract][Full Text] [Related]
6. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
7. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Chaika NV; Gebregiworgis T; Lewallen ME; Purohit V; Radhakrishnan P; Liu X; Zhang B; Mehla K; Brown RB; Caffrey T; Yu F; Johnson KR; Powers R; Hollingsworth MA; Singh PK
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13787-92. PubMed ID: 22869720
[TBL] [Abstract][Full Text] [Related]
8. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
9. MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors.
Kitamoto S; Yokoyama S; Higashi M; Yamada N; Takao S; Yonezawa S
Oncogene; 2013 Sep; 32(39):4614-21. PubMed ID: 23108411
[TBL] [Abstract][Full Text] [Related]
10. Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression.
Xu H; Inagaki Y; Seyama Y; Hasegawa K; Sugawara Y; Du G; Wang F; Tang W; Kokudo N
Life Sci; 2011 Jun; 88(23-24):1063-9. PubMed ID: 21466814
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.
Singh PK; Wen Y; Swanson BJ; Shanmugam K; Kazlauskas A; Cerny RL; Gendler SJ; Hollingsworth MA
Cancer Res; 2007 Jun; 67(11):5201-10. PubMed ID: 17545600
[TBL] [Abstract][Full Text] [Related]
13. AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.
Norris AM; Gore A; Balboni A; Young A; Longnecker DS; Korc M
Oncogene; 2013 Aug; 32(33):3867-76. PubMed ID: 22945649
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
He P; Yang JW; Yang VW; Bialkowska AB
Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
[TBL] [Abstract][Full Text] [Related]
15. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.
Roy LD; Sahraei M; Subramani DB; Besmer D; Nath S; Tinder TL; Bajaj E; Shanmugam K; Lee YY; Hwang SI; Gendler SJ; Mukherjee P
Oncogene; 2011 Mar; 30(12):1449-59. PubMed ID: 21102519
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.
Merlin J; Stechly L; de Beaucé S; Monté D; Leteurtre E; van Seuningen I; Huet G; Pigny P
Oncogene; 2011 Jun; 30(22):2514-25. PubMed ID: 21258405
[TBL] [Abstract][Full Text] [Related]
18. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.
Jurcak NR; Rucki AA; Muth S; Thompson E; Sharma R; Ding D; Zhu Q; Eshleman JR; Anders RA; Jaffee EM; Fujiwara K; Zheng L
Gastroenterology; 2019 Sep; 157(3):838-850.e6. PubMed ID: 31163177
[TBL] [Abstract][Full Text] [Related]
19. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Klein E; Drebber U; Baldus SE; Cooc J; Azuma M; Metzger R; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
Neoplasia; 2008 Jul; 10(7):674-9. PubMed ID: 18592007
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
